Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

• Główni autorzy: Philip Lee (Autor), Kristin D. Kistler (Autor), Luc Douyon (Autor), Raisa Volodarsky (Autor), Alex Young (Autor), Sudeep Karve (Autor), Swetha Challagulla (Autor)
• Format: Książka
• Wydane: Adis, Springer Healthcare, 2022-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Abstract Background and Objective Ibrutinib, an oral Bruton's tyrosine kinase inhibitor, has demonstrated efficacy as a first-line treatment for chronic lymphocytic leukemia in multiple, phase III, randomized clinical trials. This systematic literature review assessed the clinical effectiveness...